|
|
|
|
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial |
Lancet Oncol., Volume 21, Issue 12, December 2020, Pages 1653-1660 | https://doi.org/10.1016/S1470-2045(20)30486-1 |
( 2020-11 ) Medicine, Immunology, Cancer Biology/Oncology | 한빛사논문 |
|